Current Funding Opportunities

ASCO Foundation

Conquer Cancer Research Funding Opportunities for Diversity and Inclusion in Breast Cancer

Multiple funding opportunities designed with the primary goal of increasing diversity in the oncology workforce and cancer research. Awards will be given to investigators who are members of racial and/or ethnic groups traditionally excluded in academic medicine and biomedical research, and who wish to conduct original breast cancer research not currently funded.

Due Date: December 14, 2021

Research Professorship Details

Advanced Clinical Research Award Details

Due Date: January 10, 2021

Young Investigator Award Details

Career Development Award Details

US Department of Veterans Affairs and NCI

Attached is an exciting post-doctoral fellowship opportunity through the NCI Big Data Scientist Training Program (BD-STEP). The Big Data Scientist Training Enhancement Program (BD-STEP) is a two-year fellowship opportunity offered through the National Cancer Institute and the Veterans Health Administration that uses data science to advance cancer research and patient care. Please check out the attached BDSTEP Fact Sheet and BDSTEP Flyer and apply today!

AACR Career Development Award for Pancreatic Cancer Research

The Lustgarten Foundation-AACR Career Development Award for Pancreatic Cancer Research, in Honor of Ruth Bader Ginsburg, has been established to honor the life and legacy of Justice Ginsburg, who worked tirelessly to advance gender equality, even while battling pancreatic cancer. The intent of this program is to support the development and diversity of talent working in pancreatic cancer research.

This Award represents a joint effort to support the career advancement of a female scientist engaged in pancreatic cancer research, more information here

Grant Amount $300,000 USD
Grant Term 3 Years
Start of Grant Term 07/01/2022
Letter of Intent Deadline 10/18/2021 1:00 PM (ET)
Letter of Intent Notification Date 12/2021
Application Deadline 01/24/2022 1:00 PM (ET)
Decision Date 3/2022
Find all current AACR opportunities here and more here!

NIH National Cancer Institute Early Detection Research Network

(NEW) Early Detection Research Network (EDRN) Funding Opportunity Announcements (FOAs): EDRN BCC, EDRN CVC, EDRN DMCC

NCI Center to Reduce Cancer Health Disparities (CRCHD)

Training and funding opportunities for CPACHE trainees and investigators:

NCI CURE K08 career development award, entitled NCI Mentored Research Scientist Development Award to Promote Diversity (K08), provides clinical scientists from underrepresented populations with up to five years of protected time for mentored research training and career development support.

Connecting Underrepresented Populations to Clinical Trials (CUSP2CT)

This new program will implement and evaluate multilevel and culturally tailored outreach and education interventions with the primary goal of increasing referral and ultimately, accrual of underrepresented racial/ethnic (R/E) minority populations, to NCI-supported clinical trials. Learn more:

NCI Mentored Research Scientist Development Award to Promote Diversity (K01)

The NCI Mentored Research Scientist Development Award to Promote Diversity (K01) is designed to enhance workforce diversity by promoting cancer research career development and mentored training experience to individuals from underrepresented groups. Learn more:

HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network

Key Dates:
• (Optional) Letter of Intent Due Date: November 28, 2021
• Application Due Date: December 28, 2021
• Scientific Merit Review: March 2022
• Advisory Council Review: May 2022
• Earliest Start Date: July 2022

RFA-CA-21-045: Coordinating Center for HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network (U24 Clinical Trial Required)

RFA-CA-21-046: Research Bases for HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network (UG1 Clinical Trial Required)

RFA-CA-21-047: Clinical Sites for HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network (UG1 Clinical Trial Required)

Cancer Research Institute

The Cancer Research Institute Technology Impact Award provides seed funding of up to $200,000 to be used over 12-24 months to address the gap between technology development and clinical application of cancer immunotherapies.

LOI Due Date: November 15, 2021

Additional details here.

Cancer Research Institute Lloyd J. Old STAR Program

The CRI Lloyd J. Old STAR Program—Scientists Taking Risks—provides long-term funding to mid-career scientists, giving them the freedom and flexibility to pursue high-risk, high-reward research at the forefront of discovery and innovation in cancer immunotherapy.

Due Date: January 15, 2022

Additional details here.